As of 2025-07-01, the Relative Valuation of Oric Pharmaceuticals Inc (ORIC) is (37.42) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.14 USD, the upside of Oric Pharmaceuticals Inc based on Relative Valuation is -469.1%.
The range of the Relative Valuation is (24.86) - (49.15) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 26.3x | 19.6x |
| Forward P/E multiples | 13.3x - 27.7x | 20.5x |
| Fair Price | (24.86) - (49.15) | (37.42) |
| Upside | -345.1% - -584.7% | -469.1% |
| Date | P/E |
| 2025-06-26 | -5.62 |
| 2025-06-25 | -5.47 |
| 2025-06-24 | -5.61 |
| 2025-06-23 | -5.35 |
| 2025-06-20 | -4.98 |
| 2025-06-18 | -4.93 |
| 2025-06-17 | -4.83 |
| 2025-06-16 | -5.04 |
| 2025-06-13 | -5.15 |
| 2025-06-12 | -5.17 |
| 2025-06-11 | -5.02 |
| 2025-06-10 | -5.22 |
| 2025-06-09 | -5.28 |
| 2025-06-06 | -4.99 |
| 2025-06-05 | -4.90 |
| 2025-06-04 | -4.86 |
| 2025-06-03 | -4.49 |
| 2025-06-02 | -4.53 |
| 2025-05-30 | -4.37 |
| 2025-05-29 | -4.26 |
| 2025-05-28 | -3.19 |
| 2025-05-27 | -3.09 |
| 2025-05-23 | -3.40 |
| 2025-05-22 | -3.18 |
| 2025-05-21 | -3.14 |
| 2025-05-20 | -3.03 |
| 2025-05-19 | -2.75 |
| 2025-05-16 | -2.53 |
| 2025-05-15 | -2.54 |
| 2025-05-14 | -2.60 |
| 2025-05-13 | -2.84 |
| 2025-05-12 | -2.89 |
| 2025-05-09 | -2.72 |
| 2025-05-08 | -2.85 |
| 2025-05-07 | -2.51 |
| 2025-05-06 | -2.70 |
| 2025-05-05 | -3.05 |
| 2025-05-02 | -3.03 |
| 2025-05-01 | -2.98 |
| 2025-04-30 | -3.06 |
| 2025-04-29 | -3.03 |
| 2025-04-28 | -2.72 |
| 2025-04-25 | -2.73 |
| 2025-04-24 | -2.78 |
| 2025-04-23 | -2.77 |
| 2025-04-22 | -2.79 |
| 2025-04-21 | -2.61 |
| 2025-04-17 | -2.55 |
| 2025-04-16 | -2.51 |
| 2025-04-15 | -2.70 |